Stay updated on Linzagolix Efficacy in Endometriosis Pain Clinical Trial
Sign up to get notified when there's something new on the Linzagolix Efficacy in Endometriosis Pain Clinical Trial page.

Latest updates to the Linzagolix Efficacy in Endometriosis Pain Clinical Trial page
- Check6 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no visible changes to study data or navigation.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The notice about government funding lapse and the previous Revision: v3.4.1 notice have been removed.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary is added to the page, and there are UI/metadata updates including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision label of v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdds Revision: v3.3.4 and removes Revision: v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedLocation details are now presented under a single 'Locations' section, replacing the prior state-by-state location blocks. The record shows a new revision tag v3.3.3 and removes the HHS Vulnerability Disclosure link.SummaryDifference2%

Stay in the know with updates to Linzagolix Efficacy in Endometriosis Pain Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linzagolix Efficacy in Endometriosis Pain Clinical Trial page.